Physician
Children First Pediatrics of Virginia, P.C.
Children First Pediatrics of Virginia, P.C. was paid $3.99M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoCHILDREN FIRST PEDIATRICS OF VIRGINIA, P.C.
MARTINSVILLE, VA 24112
MARTINSVILLE, VA 24112
33aNPI1942651054assigned 06/29/2016
33bProvider typePediatrics Physician
28Total paid$3.99M
24GClaims184,732
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#43 of 817
Median peer was paid$29K
This provider vs. median136×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,204 | $63K | |
| 2019 | 7,873 | $198K | |
| 2020 | 12,862 | $299K | |
| 2021 | 26,951 | $581K | |
| 2022 | 37,986 | $802K | |
| 2023 | 42,283 | $900K | |
| 2024incomplete | 54,573 | $1.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 15,143 | 12,347 | $1.18M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 14,918 | 12,415 | $799K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.9% | 4,407 | 4,033 | $316K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.6% | 4,237 | 3,495 | $262K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 5.3% | 2,000 | 1,609 | $213K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.6% | 2,062 | 1,872 | $144K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.4% | 10,749 | 4,746 | $134K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.9% | 9,301 | 7,984 | $117K |
| 90677 | 2.5% | 881 | 648 | $99K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 2,877 | 2,449 | $76K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 5,881 | 4,512 | $47K |
| 90723 | 1.1% | 2,456 | 2,114 | $43K |
59 more codes
| 90670 | <1% | 2,378 | $38K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 467 | $34K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,147 | $31K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 306 | $30K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15,703 | $29K |
| 90680 | <1% | 1,529 | $28K | |
| 96160 | <1% | 13,442 | $27K | |
| 99381 | <1% | 476 | $26K | |
| 99188 | <1% | 1,301 | $25K | |
| 90648 | <1% | 2,387 | $23K | |
| 87807 | <1% | 1,831 | $21K | |
| 90633 | <1% | 1,647 | $20K | |
| 85018 | <1% | 7,636 | $16K | |
| 90710 | <1% | 384 | $16K | |
| 94760 | <1% | 14,054 | $15K | |
| 83655 | <1% | 1,254 | $13K | |
| 96127 | <1% | 2,928 | $13K | |
| 90651 | <1% | 196 | $13K | |
| 92551 | <1% | 1,367 | $12K | |
| 90461 | <1% | 5,629 | $10K | |
| 90686 | <1% | 820 | $10K | |
| 99177 | <1% | 2,483 | $10K | |
| 81002 | <1% | 3,665 | $9K | |
| 90716 | <1% | 369 | $9K | |
| 90681 | <1% | 499 | $8K | |
| 90734 | <1% | 193 | $8K | |
| 99173 | <1% | 3,342 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 673 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 562 | $6K |
| 90707 | <1% | 352 | $6K | |
| 90696 | <1% | 332 | $5K | |
| 96161 | <1% | 2,722 | $5K | |
| 87634 | <1% | 96 | $4K | |
| 90700 | <1% | 342 | $4K | |
| 90647 | <1% | 392 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 285 | $2K |
| 69210 | <1% | 52 | $2K | |
| 94664 | <1% | 205 | $2K | |
| 80061 | Lipid panel | <1% | 186 | $2K |
| 90685 | <1% | 163 | $2K | |
| 81003 | <1% | 618 | $1K | |
| 36416 | <1% | 8,224 | $1K | |
| 99000 | <1% | 1,476 | $878.28 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $803.95 |
| 99401 | <1% | 39 | $759.30 | |
| 90661 | <1% | 114 | $702.95 | |
| 90715 | <1% | 43 | $669.10 | |
| 0071A | <1% | 16 | $666.00 | |
| 0072A | <1% | 14 | $584.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 383 | $311.23 |
| 99072 | <1% | 3,286 | $196.32 | |
| 69209 | <1% | 34 | $170.48 | |
| 99050 | <1% | 14 | $114.34 | |
| 99051 | <1% | 593 | $50.09 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 413 | $44.95 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 30 | $32.49 |
| A9150 | Non-prescription drugs | <1% | 621 | $25.70 |
| 94761 | <1% | 13 | $14.48 | |
| 91307 | 0% | 80 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNOONAN, MARY (PEDIATRICIAN/OWNER)